QQ客服 官方微博 反馈留言

	An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer.
	He, Jianxing; Shi, Yuankai; Chang, Jianhua; Wang, Mengzhao; Han, Baohui; Liu, Xiaoqing; Chen, Gongyan; Zhou, Caicun; Liu, Jiwei; Pan, Hongming
	2015
卷号	33期号:15
ISSN号	0732-183X
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6386381
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	He, Jianxing,Shi, Yuankai,Chang, Jianhua,et al. An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer.[J],2015,33(15).
APA	He, Jianxing.,Shi, Yuankai.,Chang, Jianhua.,Wang, Mengzhao.,Han, Baohui.,...&Wang, Liwei.(2015).An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer..,33(15).
MLA	He, Jianxing,et al."An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer.".33.15(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。